Plus Therapeutics | CYTX - Cash And Equivalent


Plus Therapeutics reported $3.02M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Baxter International USD 2.02B 51M Mar/2026
Cerus USD 19.96M 4.29M Dec/2025
Dr.Reddys Laboratories INR 18.66B 8.75B Dec/2025
Haemonetics USD 245.44M 117.93M Mar/2026
Northwest Biotherapeutics USD 4.56M 244K Sep/2025
Plus Therapeutics USD 3.02M 1.23M Mar/2026
Sanofi EUR 7.66B 1.25B Dec/2025
Starpharma Holdings AUD 15.41M 4.87M Jun/2025
Sun Pharmaceuticals INR 113.32B 33.19B Mar/2025
Teva Pharmaceutical Industries USD 3.56B 1.35B Dec/2025